Skip to main content
. 2017 Nov 15;67(2):334–342. doi: 10.2337/db17-1142

Figure 2.

Figure 2

A: Brain regions in the PET study where insulin-stimulated GU was measured in carriers and noncarriers of the p.P50T/AKT2 variant. B: Significant differences (P value) in GU in the specific regions of the brain between noncarriers (blue bars, N = 25) and carriers (red bars, N = 20) of the p.P50T/AKT2 variant. Data are mean ± SD.

HHS Vulnerability Disclosure